Black Hawk Acquisition Corp. to Merge with Vesicor Therapeutics in $70M Business Combination

Black Hawk Acquisition Corporation (NASDAQ: BKHA) filed an amended S-4 registration statement for a proposed merger with Vesicor Therapeutics, Inc., valuing the combined entity at $70 million equity value. The transaction includes a $10 million private placement investment as a closing condition and

• spac merger
• vesicor therapeutics
• nasdaq listing
• business combination